James M. Daly, Director at MADRIGAL PHARMACEUTICALS, INC. (MDGL), sold 63,057 shares at $255.64 ($15.9M) on 2024-04-01, disclosed to the SEC on 2024-04-03.
Scheduled sale ($15.9M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $255.64 | 6,809 | $1.7M | 10.9% |
| 2 | $255.64 | 6,809 | $1.7M | 10.9% |
| 3 | $256.50 | 7,401 | $1.9M | 11.9% |
| 4 | $256.50 | 7,401 | $1.9M | 11.9% |
| 5 | $257.30 | 3,604 | $927K | 5.8% |
| 6 | $257.30 | 3,604 |
| $927K |
| 5.8% |
| 7 | $258.28 | 1,460 | $377K | 2.4% |
| 8 | $258.28 | 1,460 | $377K | 2.4% |
| 9 | $259.11 | 200 | $52K | 0.3% |
| 10 | $262.01 | 800 | $210K | 1.3% |
| 11 | $263.31 | 178 | $47K | 0.3% |
| 12 | $264.89 | 351 | $93K | 0.6% |
| 13 | $264.89 | 351 | $93K | 0.6% |
| 14 | $265.49 | 500 | $133K | 0.8% |
| 15 | $266.91 | 274 | $73K | 0.5% |
| 16 | $266.91 | 274 | $73K | 0.5% |
| 17 | $243.26 | 842 | $205K | 1.3% |
| 18 | $243.26 | 842 | $205K | 1.3% |
| 19 | $244.19 | 6,279 | $1.5M | 9.6% |
| 20 | $244.19 | 6,279 | $1.5M | 9.6% |
| 21 | $244.89 | 2,991 | $732K | 4.6% |
| 22 | $244.89 | 2,991 | $732K | 4.6% |
| 23 | $246.30 | 557 | $137K | 0.9% |
| 24 | $246.30 | 557 | $137K | 0.9% |
| 25 | $247.03 | 43 | $11K | 0.1% |
| 26 | $248.45 | 200 | $50K | 0.3% |
| Total | $252.72 avg | 63,057 | $15.9M | 100% |
| Filing → |
| HALO | SELL | 2023-08-15 | $875K | — | Filing → |
| HALO | SELL | 2020-11-25 | $838K | — | Filing → |
| HALO | SELL | 2020-08-13 | $2.0M | — | Filing → |